Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From the coconut farms of the Philippines to refrigerators across the U.S., Vita Coco turns raw coconuts into a global hydration franchise. That supply chain—and the social commitments behind it—surface in every SEC document. If you’ve searched for “Vita Coco SEC filings explained simply” or wondered how sustainability costs flow through the P&L, this page delivers the answers.
Here you will find the “Vita Coco annual report 10-K simplified” to track segment growth in The Americas, the “Vita Coco quarterly earnings report 10-Q filing” that reveals coconut cost inflation, and the “Vita Coco 8-K material events explained” whenever sourcing disruptions arise. Need to monitor management moves? Our dashboard surfaces “Vita Coco insider trading Form 4 transactions,” “Vita Coco Form 4 insider transactions real-time,” and “Vita Coco executive stock transactions Form 4” the moment they hit EDGAR. Corporate governance questions? Scan the “Vita Coco proxy statement executive compensation” to see how bonus targets align with carbon reduction goals. Each document includes concise summaries and real-time alerts.
Stock Titan’s AI distills every note into clear language, so “understanding Vita Coco SEC documents with AI” means you can jump straight to coconut-water revenue, cash flow, or sustainability metrics. Receive instant notifications, compare “Vita Coco earnings report filing analysis” quarter over quarter, and export numbers directly to your models. Save hours and make confident decisions with complete, up-to-date information.
Vita Coco (COCO) Executive Chairman and Director Michael Kirban reported open‑market sales made under a Rule 10b5‑1 trading plan. He sold 30,000 shares at $45.701 on 10/29/2025 and 14,898 shares at a weighted average price of $44.211 on 10/30/2025.
The 10/30 transactions occurred in multiple trades between $44.00 and $45.00. Following the reported sales, beneficial ownership reported included 1,484,151 shares held indirectly by the Michael Kirban 2010 Trust, plus 127,629 shares held directly and 615,681 shares held indirectly by the Michael Kirban Revocable Trust.
Reported derivative holdings include non‑qualified stock options to purchase 546,000 shares at $10.178 expiring 12/16/2029 (fully vested), 298,507 shares at $15 expiring 10/21/2031, and 70,715 shares at $32.78 expiring 03/03/2035, among others, with specified vesting schedules.
Vita Coco (COCO) reported insider activity by Chief Operating Officer Jonathan Burth. On 10/29/2025, he exercised stock options at $10.178 per share for 2,334 and 20,000 shares (code M), then sold the same amounts (code S) at weighted average prices of $47.948 and $45.711, respectively, pursuant to a Rule 10b5-1 trading plan.
Following these transactions, Burth directly beneficially owned 76,127 shares of common stock. The filing also lists multiple outstanding non-qualified stock options with stated exercise prices and expirations, including grants expiring between 2029 and 2035, with various vesting schedules as disclosed.
Vita Coco (COCO) CEO and Director Martin Roper filed a Form 4 reporting open-market sales of common stock on 10/29/2025 and 10/30/2025 made under a Rule 10b5-1 trading plan.
Direct transactions included 5,000 shares at a weighted average price of $46.087 on 10/29 and 500 shares at $45.00 on 10/30. Indirect transactions included 5,000 shares at a weighted average $46.108 on 10/29 and 500 shares at $45.00 on 10/30 by the Christopher G. Roper Exempt Family Trust, plus 5,000 shares each on 10/29 by the Peter S. Roper and Thomas L. Roper Exempt Family Trusts at weighted average prices within the disclosed ranges.
Following these transactions, reported beneficial holdings were 281,562 shares (direct), 215,631 (Christopher G. Roper Exempt Family Trust), 216,131 (Peter S. Roper Exempt Family Trust), 216,131 (Thomas L. Roper Exempt Family Trust), and 61,200 (by spouse).
The Vita Coco Company (COCO) reported higher Q3 2025 results. Net sales were $182.3 million versus $132.9 million a year ago, with gross profit of $68.7 million versus $51.6 million. Income from operations rose to $27.9 million from $20.6 million, and net income was $24.0 million versus $19.3 million. Diluted EPS was $0.40 compared with $0.32. For the nine months, net sales reached $482.0 million and net income was $65.8 million, with diluted EPS of $1.10.
Cash and cash equivalents were $203.7 million as of September 30, 2025. The company had no borrowings and $60.0 million available under its amended revolving credit facility, now maturing in 2030. Two customers accounted for 45% of year-to-date net sales. The board expanded the share repurchase authorization to $65.0 million; year-to-date repurchases totaled 338,416 shares for $10.2 million, leaving $42.0 million authorized. Management highlighted U.S. tariffs, citing a current blended rate of about 23% based on quarter-end sourcing, with review scheduled in November 2025.
The Vita Coco Company, Inc. (COCO) furnished an update on its operations by announcing financial results for the three months ended September 30, 2025. The results were disclosed through a press release furnished as Exhibit 99.1 to a Form 8-K under Item 2.02. The company noted that the information is being furnished and not deemed filed for purposes of Section 18 of the Exchange Act.
Vita Coco Company (COCO) reported an insider transaction by a director. On 10/15/2025, the reporting person sold 3,900 shares of common stock at a weighted average price of $38.915 under a Rule 10b5-1 trading plan. Following the sale, the insider directly beneficially owns 619,966 shares.
The filing also lists a non-qualified stock option to buy 27,300 shares at an exercise price of $10.178, fully vested and currently exercisable, with an expiration date of 01/02/2030.
Martin Roper, listed as Director and Chief Executive Officer of Vita Coco Company, Inc. (COCO), reported sales of a total of 7,894 shares of common stock on
Vita Coco Company, Inc. (COCO) reported insider sales by Martin Roper executed under a Rule 10b5-1 trading plan. The filing shows multiple dispositions of 5,000 shares on
The form also lists fully vested and exercisable non-qualified stock options and other option grants: a large exercisable option for 579,670 shares at an exercise price of
Martin Roper, listed as Director and Chief Executive Officer of Vita Coco Company, Inc. (COCO), reported multiple sales of company common stock under a Rule 10b5-1 trading plan executed on 10/01/2025 and 10/02/2025. The filings show repeated disposals of 5,000-share blocks at weighted average prices in the low $42 range (reported ranges between $41.79 and $42.66). Following the reported 10/01 sale the filing shows 303,897 shares beneficially owned directly; following the 10/02 sale that direct ownership is shown as 298,897. The Form 4 also discloses multiple indirect holdings by related family trusts and a spouse, and reports several non-qualified stock options with exercise prices from $10.178 to $32.78, some fully vested and currently exercisable and others subject to multi-year vesting schedules.
Insider transactions by Vita Coco Company, Inc. (COCO) show the chief operating officer engaged in a planned sale of 3,173 shares of common stock under a Rule 10b5-1 trading plan at $42.50 per share, which reduced his direct holdings from 79,300 to 76,127 shares. The filing also reports the grant and continued ownership of multiple non-qualified stock options with exercise prices ranging from $10.178 to $33.36, some fully vested and exercisable and others subject to multi-year vesting schedules. The disclosure records routine option grants and an executed plan-based sale, providing transparency about executive equity and compensation.
FAQ
What is the current stock price of Vita Coco Company (COCO)?
What is the market cap of Vita Coco Company (COCO)?
